AXA


Lower expectations, but always good to buy

03/12/18 -"We have updated our figures for AXA after a series a strategic news and moves. The insurer, initially hit by its decision to acquire XL Group, now confirms that its decision was right. The decrease ..."

Pages
51
Language
English
Published on
03/12/18
You may also be interested by these reports :
16/05/19
Q1 19 premium income remained stable (up 0.6% yoy at constant FX) to €8,549m. Sales in France declined by 1.7% yoy to €5,879m, while the Brazilian ...

16/05/19
Again, Generali confirmed it was in good health. Life and Non-Life sales improved by 8.5% and 3.1% to €12,502m and €6,371m, respectively. The ...

15/05/19
Ageas posted an 8% increase in its inflows to €12,808m, driven by both the Life and Non-Life businesses. The net result was up 1.2% to €251m, saved ...

14/05/19
• Net profit attributable to shareholders increased by 2% to €1.97bn for Q1 19 • RoE was 13.7% in Q1 19 despite an increase in shareholders’ funds of ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO